Singapore Health News API

{
    "totalArticles": 52150,
    "articles": [
        {
            "id": "1cdd4a27cd05ddaeb8674ad733247a1b",
            "title": "GLP-1 drugs show promise in managing chronic migraines",
            "description": "Chronic migraine patients taking GLP-1s are associated with fewer ER visits, hospitalizations and treatment interventions than those taking a common first-line migraine drug, a study shows.",
            "content": "GLP-1 drugs, including Novo Nordisk's Wegovy and Ozempic, could also help people who have chronic migraines, a real-world observational study suggests.\nChronic migraine patients who took certain GLP-1 receptor agonists, which are most commonly used t... [3028 chars]",
            "url": "https://www.techtarget.com/pharmalifesciences/news/366640757/GLP-1-drugs-show-promise-in-managing-chronic-migraines",
            "image": "https://www.techtarget.com/rms/onlineimages/pharma_g1155870514.jpg",
            "publishedAt": "2026-03-25T20:37:30Z",
            "lang": "en",
            "source": {
                "id": "66f3ceef50501752180caf51515073e9",
                "name": "TechTarget",
                "url": "https://www.techtarget.com"
            }
        },
        {
            "id": "c3fbe1a1b4a3fc736c4bed234e080b1c",
            "title": "Italy tracks first European human H9N2 avian flu case",
            "description": "About 90% of human H9N2 avian flu cases have been reported in China.",
            "content": "New research from Argentina suggests a potential link between a commonly used herbicide and antimicrobial resistance (AMR).\nIn a study published this week in Frontiers in Microbiology, a team led by researchers from the University of Buenos Aires ass... [2294 chars]",
            "url": "https://www.cidrap.umn.edu/avian-influenza-bird-flu/italy-tracks-first-european-human-h9n2-avian-flu-case",
            "image": "https://www.cidrap.umn.edu/themes/custom/cidrap_theme/images/cidrap-og-image.jpg",
            "publishedAt": "2026-03-25T19:01:00Z",
            "lang": "en",
            "source": {
                "id": "29fcba365dad1c5ca0a8efcd57b4bc8e",
                "name": "CIDRAP",
                "url": "https://www.cidrap.umn.edu"
            }
        },
        {
            "id": "74202bbc1f01950bd72f9db19a762dad",
            "title": "Dramatic reduction in prescribing of hepatitis C antivirals may leave many curable patients untreated",
            "description": "Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment within a year of diagnosis. A new study by investigators from Mass General Brigham and University of Virginia School of Medicine has analyzed a large national prescription database to estimate hepatitis C treatment courses over time and trends by patient and prescriber characteristics from 2013–2025.",
            "content": "Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment within a year of diagnosis. A new study by investigators from Mass General Brigham and U... [1076 chars]",
            "url": "https://medicalxpress.com/news/2026-03-reduction-hepatitis-antivirals-curable-patients.html",
            "image": "https://scx2.b-cdn.net/gfx/news/hires/2024/prescription-pills.jpg",
            "publishedAt": "2026-03-25T18:50:02Z",
            "lang": "en",
            "source": {
                "id": "fc12437cc984742bf9a97820262ab48a",
                "name": "Medical Xpress",
                "url": "https://medicalxpress.com"
            }
        }
    ]
}